Molecular Docking and<i> In Silico</i> ADMET Study Reveals Acylguanidine 7a as a Potential Inhibitor of <i>β</i>-Secretase

<div>Binding energy values of the test ligands; MK-8931 is the study control.</div>

Advances in Bioinformatics

Figure 8: Molecular Docking and<i> In Silico</i> ADMET Study Reveals Acylguanidine 7a as a Potential Inhibitor of <i>β</i>-Secretase 